Demant A/S : Very impressive performance of hearing aids continues
>Q2 continued the strong performance - Demant’s preliminary Q2 revenues of DKK 5,647m (+15.4% y-o-y) were driven by an impressive organic growth of 12% (vs ODDO BHF 8%/consensus 11%) and were a beat of 2% of the consensus and 5% ahead of our forecast. H1 EBIT reached DKK 2,014m (+26.8% y-o-y, margin 18.1%, in line with ODDO BHF, but 5% below the consensus) driven by operating leverage in Hearing healthcare, while Communication had a negative impact. Very ...William Demant Holding is a holding company. Through its subsidiaries, Co develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. Co. focuses on four areas: Hearing Devices, Diagnostic Instruments, Hearing Implants and Personal Communication. Co.'s hearing devices include Oticon, Bernafon, Sonic, Phonic Ear, and FrontRow. Co.'s Hearing implant consist of Oticon Medical. Co.'s diagnostic instruments include Maico, Interacoustics, Amplivox, Grason-Stadler, MedRx, and Micromedical. Co.'s personal communication consists of Sennheiser Communications.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.